Cue Biopharma Inc Profit margin
What is the Profit margin of Cue Biopharma Inc?
The Profit margin of Cue Biopharma Inc is -924.10%
What is the definition of Profit margin?
Profit margin is a measure of profitability and is calculated by finding the net profit as a percentage of the revenue.
lfy (last fiscal year)
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Profit margin of companies in the Health Care sector on NASDAQ compared to Cue Biopharma Inc
What does Cue Biopharma Inc do?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Companies with profit margin similar to Cue Biopharma Inc
- Tiger Resource Plc has Profit margin of -944.17%
- KwikClick has Profit margin of -939.34%
- 102570 has Profit margin of -934.59%
- Everton Resources has Profit margin of -929.67%
- Pressure BioSciences has Profit margin of -929.64%
- A1 Investments & Resources Ltd has Profit margin of -925.93%
- Cue Biopharma Inc has Profit margin of -924.10%
- Airway Medix S.A has Profit margin of -923.74%
- Verditek plc has Profit margin of -914.81%
- Asensus Surgical Inc has Profit margin of -914.46%
- Kangaroo Island Plantation Timbers has Profit margin of -912.26%
- Cytocom Inc has Profit margin of -912.16%
- PharmAust has Profit margin of -910.93%